CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Innovative radiotherapy offers a precision treatment alternative.

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

The expansion will involve the construction of a new buffer media facility and represents the largest investment from ...

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, ...